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Targeted Disruption of Inducible Nitric Oxide Synthase
Protects Against Aging, S-Nitrosation, and Insulin
Resistance in Muscle of Male Mice
Eduardo R. Ropelle,1,2 José R. Pauli,2 Dennys E. Cintra,2 Adelino S. da Silva,3 Cláudio T. De Souza,4
Dioze Guadagnini,1 Bruno M. Carvalho,1 Andrea M. Caricilli,1 Carlos K. Katashima,1
Marco A. Carvalho-Filho,1 Sandro Hirabara,5 Rui Curi,5 Lício A. Velloso,1 Mario J.A. Saad,1 and
José B.C. Carvalheira1
Accumulating evidence has demonstrated that S-nitrosation of pro-
teins plays a critical role in several human diseases. Here, we ex-
plored the role of inducible nitric oxide synthase (iNOS) in the
S-nitrosation of proteins involved in the early steps of the in-
sulin-signaling pathway and insulin resistance in the skeletal
muscle of aged mice. Aging increased iNOS expression and
S-nitrosation of major proteins involved in insulin signaling,
thereby reducing insulin sensitivity in skeletal muscle. Conversely,
aged iNOS-null mice were protected from S-nitrosation–induced in-
sulin resistance. Moreover, pharmacological treatment with an iNOS
inhibitor and acute exercise reduced iNOS-induced S-nitrosation
and increased insulin sensitivity in the muscle of aged animals.
These ﬁndings indicate that the insulin resistance observed in
aged mice is mainly mediated through the S-nitrosation of the
insulin-signaling pathway. Diabetes 62:466–470, 2013
In recent decades, S-nitrosation, the reaction of nitricoxide (NO) with cysteine residues in proteins to formS-nitrosothiol adducts, in addition to phosphorylation,acetylation, and ubiquitination, has become one of the
main forms of post-translational modiﬁcation of intracellular
eukaryotic proteins (1). Deregulated S-nitrosation contrib-
utes to a range of chronic human diseases (1,2).
NO donor agents and the NO produced by inducible NO
synthase (iNOS) induces insulin resistance through the
S-nitrosation of proteins involved in the early steps of in-
sulin action, such as insulin receptor b (IRb), insulin re-
ceptor substrate 1 (IRS-1), and Akt (3–5). Although several
studies suggest that NO and iNOS could be involved in
several aging-related diseases (2,6), the participation of
these molecules on aging-induced insulin resistance is
unclear. Here, we hypothesized that iNOS could mediate
the insulin resistance through the S-nitrosation of insulin-
signaling pathway proteins during aging.
RESEARCH DESIGN AND METHODS
Animals. Male C57BL/6 and iNOS-null mice were purchased from Jackson
Laboratory (C57BL/6-Nos2tm1Lau colony), aged 3 months (young) and 28 months
(old). Animals had free access to standard rodent chow and water. All experi-
ments were approved by the ethics committee of the State University of Campinas.
L-N6-(l-iminoethyl) lysine (L-NIL) treatment. The animals received an
intraperitoneal injection of L-NIL (80 mg/kg body weight) or PBS, twice daily
for 5 days (n = 8).
Exercise protocol. The animals swam in for two 1.5-h-long bouts, separated
by a 30-min rest period (n = 8), in water maintained at ;34°C. This exercise
protocol was adapted from a previously published procedure (7).
Glucose and serum insulin quantiﬁcation. Serum insulin concentration was
determined using a commercially available enzyme linked immunosorbent
assay kit (Crystal Chem Inc.; n = 12). Fasting glucose was measured using
Accutrend Plus equipment (Roche); in this case, the blood sample was
obtained from the tails of mice (n = 12).
Hyperinsulinemic-euglycemic clamp. After a 6-h fast, the mice (n = 8) were
anesthetized with a mixture of ketamine (100 mg) and diazepam (0.07 mg;
0.2 mL/100 g body weight). A 120-min hyperinsulinemic-euglycemic clamp pro-
cedure was conducted continuously infused at a rate of 5.0 mU/kg body weight $
min to raise the plasma insulin concentration to ;4.8–5.4 ng/mL. Glucose (5%)
was infused at variable rates to maintain plasma glucose at 100 6 10 mg/dL.
Glucose uptake measurement. The glucose uptake in isolated soleus muscle
was performed as previously described (3). At 1 h after the last L-NIL injection
and 8 h after the exercise protocol, the mice (n = 8) were anesthetized and
soleus muscles were isolated and incubated in Krebs-Ringer bicarbonate
buffer and 0.011 MBq/mL d-[U-14C]glucose, with 95% O2/5% CO2, at 37°C and
centrifuged at 1,000g. Incubation was performed for 1 h in the presence of 10
mUI/mL insulin and 2 or 20 mmol/L glutamine. Uptake of 2-deoxy-D-[2,6-3H]
glucose was determined as previously described (8).
Protein analysis by immunoblotting. Insulin (1026 mol/L) or saline were
infused in the portal vein, and 90 s later, both portions of gastrocnemius (red
and white ﬁbers) were ablated, pooled, minced coarsely, and homogenized
immediately in extraction buffer (n = 8), and Western blot was performed, as
previously described (9).
Detection of S-nitrosated proteins by biotin switch method. The biotin-
switch assay was performed essentially as previously described (10,11) to de-
termine the IRb, IRS-1, and Akt S-nitrosation in the gastrocnemius muscle (n = 8).
Statistical analysis. Data were analyzed by the two-tailed unpaired Student
t test or by one-way ANOVA, followed by post hoc analysis of signiﬁcance
(Bonferroni test) when appropriate, comparing experimental and control
groups. The level of signiﬁcance was set at P , 0.05.
RESULTS
To explore the role of iNOS on insulin sensitivity during
aging, we analyzed insulin sensitivity in young and old wild-
type and iNOS-null male mice. During aging, wild-type and
iNOS-null old mice presented similar values for body weight
and epididymal fat weight (Fig. 1A and B). High levels of
fasting serum insulin levels were found in wild-type old
mice but not in iNOS-null mice (Fig. 1C), and fasting blood
glucose levels were similar between the groups (data not
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shown). The hyperinsulinemic-euglycemic clamp revealed
that the glucose infusion rate was 13% higher in iNOS-null
young mice compared with wild-type young mice (Fig. 1D).
In old mice, compared with the respective young group,
there was a signiﬁcant reduction in the insulin sensitivity of
control mice compared with iNOS-null mice (Fig. 1D). We
observed a strong reduction in the glucose infusion rate in
wild-type mice compared with iNOS-null mice after the
aging period (Fig. 1E). The reduction in the glucose infusion
rate was ;61% in wild-type mice and ;31% in iNOS-null
mice. Protection against the development of insulin re-
sistance in iNOS-null mice has also been observed in pre-
vious studies involving obesity models (12,13).
In addition, we observed that young iNOS-null mice
showed higher (15%) insulin-induced glucose uptake in the
FIG. 1. Insulin sensitivity in wild-type (WT) and iNOS-null male mice
after aging. Total body weight (BW) (A), epididymal fat weight (B), and
fasting insulin (8-h fast) (C). Hyperinsulinemic-euglycemic clamp glu-
cose infusion rate (GIR) (D) and variation in the GIR (E). F: Glucose
uptake in the isolated soleus muscle after insulin incubation. G: GIR
values are expressed as micromoles per gram of muscle variation. The
bars represent the mean 6 SEM of 8–12 mice. One-way ANOVA was
used in A–D and F. Student t test was used in E and G. *P < 0.05 vs. the
respective young group. §P< 0.05, young iNOS-null vs. young wild-type.
#P < 0.05, vs. wild-type.
FIG. 2. Insulin signaling and S-nitrosation of IR, IRS-1, and Akt in the
skeletal muscle of wild-type and iNOS-null male mice after aging.
A: Western immunoblot (IB) analysis was performed to evaluate iNOS,
eNOS, and nNOS expression. B: IKKb (Ser 180) phosphorylation and
TNF-a expression. IRb (Tyr 1162/1163) (C), IRS-1 (Tyr 971) (D), and
Akt (Ser 473) (E) phosphorylation in the gastrocnemius muscle. The
biotin switch method was used to determine IRb (F), IRS-1 (G), and Akt
S-nitrosation (H) in the gastrocnemius muscle. I: Glucose uptake in
isolated soleus muscle inoculated with GSNO (0, 1, 5 and 10 mmol/L)
during 30 min in the presence or absence of insulin (10 mUI/mL). J: IRb
(Tyr 1162/1163), IRS-1 (Tyr 971), and Akt (Ser 473) phosphorylation in
the isolated soleusmuscle in the presence or absence of GSNO (10mmol/L).
IRb (K), IRS-1 (L), and Akt S-nitrosation (M) in the isolated soleus muscle
incubated with GSNO (10 mmol/L). The results of scanning densitometry
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soleus muscle compared with young wild-type mice (Fig.
1F). In the aged groups, both groups demonstrated impair-
ment in the action of insulin in muscle compared with the
respective younger groups (Fig. 1F). However, the variation
in the reduction in insulin-induced glucose uptake in the
skeletal muscle after aging was more pronounced in wild-
type mice than in iNOS-null animals (Fig. 1G). The re-
duction in the glucose uptake was ;44% in wild-type mice
and ;21% in iNOS-null mice. In aged animals, iNOS-null
mice presented a higher gastrocnemius muscle weight than
wild-type mice (169 6 8.1 vs. 148.2 6 7.4 mg, P , 0.05).
Western blot analysis showed that aging increased iNOS
expression by ;180% in the skeletal muscle of wild-type
mice (Fig. 2A). We also evaluated the expression of the
other NOS isoforms and inﬂammatory markers. Aging re-
duced endothelial NOS and neuronal NOS expression and
increased inhibitor of nuclear factor k-B (IKKb) phosphor-
ylation and tumor necrosis factor (TNF)-a expression in
wild-type and iNOS-null animals in a similar fashion (Fig. 2A
and B). We observed that insulin induced a 10–15% increase
in IRb, IRS-1, and Akt phosphorylation in the muscle of
young iNOS-null mice compared with young wild-type ani-
mals (Fig. 2C–E). Wild-type mice presented reductions in
IRb, IRS-1, and Akt phosphorylation (43, 71, and 48%, re-
spectively) after aging, whereas the impairment in insulin
signaling in the skeletal muscle of iNOS-null mice was rel-
atively minor (18, 22 and 16%, respectively; Fig. 2C–E). In
parallel, aging increased IRb, IRS-1, and Akt S-nitrosation in
the muscle of wild-type but not in iNOS-null mice (Fig. 2F
and G). In this genetic approach, we demonstrated that
iNOS modulates IRb, IRS-1, and Akt S-nitrosation and in-
sulin sensitivity in the muscle of aged mice, without af-
fecting other NOS isoforms and inﬂammatory signaling.
To determine whether NO leads to insulin resistance,
isolated soleus muscle from young wild-type mice were
incubated with increasing NO donor, S-nitrosoglutathione
(GSNO). We observed that GSNO reduced insulin-induced
glucose uptake in a dose-dependent manner (Fig. 2I). In
parallel, GSNO reduced the insulin-induced IRb, IRS-1, and
Akt phosphorylation (Fig. 2J) and markedly increased the
S-nitrosation of these proteins (Fig. 2K–M).
To extend our hypothesis, we used pharmacological
(L-NIL treatment) and physiological (exercise) approaches
to reduce iNOS activity and expression, respectively (14).
We observed that neither L-NIL treatment nor exercise
changed the total body weight, epididymal fat weight, or
fasting insulin serum levels in aged mice compared with
aged mice treated with vehicle (Fig. 3A–C). However, the
clamp procedure revealed that L-NIL treatment and exer-
cise were able to increase insulin sensitivity in aged mice
compared with aged mice treated with vehicle (Fig. 3D). In
addition, L-NIL treatment and exercise signiﬁcantly in-
creased insulin-stimulated glucose uptake in the soleus
muscle in old mice (Fig. 3E).
We observed that exercise was able to reduce iNOS and
increase endothelial NOS and neuronal NOS expression in
the skeletal muscle of aged mice, whereas L-NIL treatment
did not change the expression of these enzymes (Fig. 4A
and B). In parallel, we observed that L-NIL did not change
IKKb phosphorylation and TNF-a expression, whereas
exercise decreased IKKb phosphorylation and TNF-a ex-
pression (Fig. 4C). L-NIL treatment and exercise increase
insulin-induced IRb, IRS-1, and Akt phosphorylation to a
similar degree (by ;45, 130, and 70%, respectively) com-
pared with aged wild-type animals (Fig. 4D–F). In addition,
L-NIL treatment and physical exercise reduced age-induced
IRb, IRS-1, and Akt S-nitrosation in the skeletal muscle of
aged wild-type mice (Fig. 4G–I).
DISCUSSION
Here we demonstrated that aging increased iNOS expression,
leading to insulin resistance in the skeletal muscle through
the S-nitrosation mechanism. Genetic, pharmacological, and
physiological iNOS inhibition reduced IRb, IRS-1, and Akt
S-nitrosation and increased insulin signaling in old mice.
Our results reinforce the idea that iNOS plays a crucial role in
inducing insulin resistance, as previously shown in different
animal models such as diet-, lipopolysaccharide-, and lipid-
induced skeletal muscle insulin resistance (3,13,15,16).
In contrast to our data, Cha et al. (17) reported that iNOS
deﬁciency does not prevent age-associated insulin resistance.
In contrast to the previous study, we did not observe an in-
crease in TNF-a expression in the skeletal muscle of aged
are expressed as arbitrary units (AU). Bars represent the mean 6 SEM
of eight mice. One-way ANOVA was used in C–I. The Student t test was
used in K–M. *P < 0.05 vs. the respective young group. §P < 0.05 young
iNOS-null vs. young wild-type. &P < 0.05 vs. aged wild-type. ¶P < 0.05
vs. insulin without GSNO. ‖P < 0.05 vs. vehicle.
FIG. 3. Pharmacological and physiological iNOS inhibition improves
insulin sensitivity in aged mice. Total body weight (A), epididymal fat
weight (B), and fasting insulin (8-h fast) (C) were determined 1 h after
the last L-NIL injection or 8 h after the exercise protocol D: Hyper-
insulinemic-euglycemic clamp. E: Glucose uptake in the isolated soleus
muscle after insulin incubation is expressed as micromoles per gram of
muscle. One-way ANOVA was used. Bars represent the mean 6 SEM of
8–12 mice. *P < 0.05 vs. young wild-type (WT). #P < 0.05 vs. old mice
without L-NIL or exercise.
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iNOS-null mice compared with the aged wild-type group;
these data were conﬁrmed by analyzing IKKb phosphoryla-
tion. In accordance with our data, a previous study showed
iNOS knockout mice were protected from insulin resistance
induced by a high-fat diet (13). Furthermore, iNOS-null mice
fed a high-fat diet do not present increased TNF-a levels in
the muscle and are protected against lipopolysaccharide-
induced S-nitrosation of IRb/IRS-1 and Akt (12,15).
Accumulating evidence has demonstrated that S-
nitrosation negatively modulates insulin signaling (3,5).
Our data reveal that high levels of iNOS expression were
accompanied by IRb, IRS-1, and Akt S-nitrosation and in-
sulin resistance in aged male mice. In accordance with our
results in male mice, high levels of iNOS expression and
IR and Akt S-nitrosation were reported in the liver and
adipose tissue of aged female rodents. Altogether, these
data suggest that this phenomenon may also occur in
female mice (18,19). Wu et al. (20) reported that Akt
S-nitrosation was associated with a reduction in Akt activity
and with skeletal muscle disorders in aged mice. Although
the S-nitrosation of Akt at cysteine 224 leads to inactivation of
this kinase, the reactive cysteine residue(s) that undergo(es)
S-nitrosation in IR and IRS-1 are unknown and deserve fur-
ther investigation.
Pharmacological iNOS inhibition has been investigated
in animal models of insulin resistance and diabetes. In
accordance with the results obtained from aged mice,
L-NIL restored insulin sensitivity involving the S-nitrosation
mechanism in the muscle of obese rats (3). Beyond the
skeletal muscle, high levels of iNOS expression were also
reported in the liver of ob/obmice, whereas L-NIL treatment
was sufﬁcient to enhance insulin-induced IRS-1- and IRS-2
phosphorylation (21). Moreover, aspirin treatment im-
proved insulin signaling in the muscle of obese rats by
reducing iNOS activity (12). Interestingly, a nonacetylated
salicylate treatment, salsalate, also improved glycemic
control in diabetic patients in parallel with reductions in
the inﬂammatory response, including reduced levels of
serum nitrite, which at least in part may be secondary to
reduced iNOS activation (22).
FIG. 4. Pharmacological and physiological iNOS inhibition improves insulin signaling and reduces S-nitrosation of IRb, IRS-1, and Akt in the
skeletal muscle of aged mice. iNOS expression (A), endothelial eNOS and neuronal nNOS expression (B), and IKKb (Ser 180) phosphorylation and
TNFa expression (C) were determined 1 h after the last L-NIL injection or 8 h after the exercise protocol by immunoblotting (IB). IRb (Tyr 1162/
1163) (D), IRS-1 (E), and Akt (Ser 473) (F) phosphorylation in the gastrocnemius muscle. The biotin switch method was used to determine IRb
(G), IRS-1 (H), and Akt (I) S-nitrosation in the muscle. The results of scanning densitometry are expressed as arbitrary units (AU). White bars
indicate control group; grey bars indicate old mice plus L-NIL treatment; and black bars indicate old mice plus exercise. Bars represent the mean6
SEM of eight mice. One-way ANOVA was used. *P < 0.05 vs. young wild-type (WT). #P < 0.05 vs. aged iNOS-null.
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In the current study, we also demonstrated that after
a single bout of exercise, iNOS expression and IRb, IRS-1,
and Akt S-nitrosation were diminished; conversely, insulin
sensitivity was increased in the skeletal muscle of old
mice. These data are in accordance with previous results
observed in obese exercised rats (14). Therefore, beyond
the pharmacological and genetic approach, the physio-
logical reduction of iNOS levels induced by exercise re-
versed the deregulation of insulin signaling and insulin
resistance observed in old mice.
Beyond S-nitrosation, NO metabolites can also induce
tyrosine nitration (i.e., the covalent addition of NO2 to the
tyrosine residues of proteins) (23). It has been demon-
strated that tyrosine nitration reduces tyrosine phosphory-
lation and the activation of downstream insulin-signaling
intermediates (24). Serine phosphorylation of IRSs medi-
ated by proinﬂammatory stimuli and increased protein ty-
rosine phosphatase 1B (PTP1B) activity have been reported
as central molecular mechanisms involved in the de-
velopment of insulin resistance with aging (25). Thus, aging
elicits all of these mechanisms, which converge to cause
insulin-signaling disruption.
Collectively, our study provides evidence that the age-
related increase in muscle iNOS expression and activity is
an important contributing factor to the S-nitrosation of
insulin signaling proteins and insulin resistance in the
skeletal muscle of aged rodents.
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